Zhejiang Anglikang Pharmaceutical (002940.SZ) subsidiary obtains the approval document number for the veterinary drug product "Fusomide Tablets"
AngLiKang (002940.SZ) announced recently that its subsidiary Zhejiang AngLiKang Animal Health Technology Co., Ltd. (...)
Zhejiang Anglikang Pharmaceutical (002940.SZ) announced recently that its subsidiary, Zhejiang Anglikang Pharmaceutical Animal Protection Technology Co., Ltd. ("Animal Protection Technology"), has received the approval documents for the veterinary drug product approval number of "Furosemide Tablets" issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. Furosemide tablets are diuretic drugs for pets used to treat various edemas.
The acquisition of this veterinary drug approval number will further enrich the company's product range, and it is of great significance in promoting the strategic layout of pet drugs and promoting the company's development.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
